Vertex Pharmaceuticals (NYSE: VRTX) and developer Joe Fallon are working to advance the biotech company's plan to move to a new building on the South Boston waterfront, Boston Mayor Thomas M. Menino said Thursday afternoon. "I...
- Vertex Pharmaceuticals (VRTX: News ) has eased throughout the afternoon. The stock slumped below its 50-day and 200-day moving averages and is at its lowest level since mid-September, down $3.51 at $25.59. by RTT Staff Writer...
The industry's longest running and most comprehensive event dedicated to validation compliance training. Validation Week will take place at the Doubletree Hotel in Philadelphia, PA from October 21-23, 2008
If you're thinking of selling your stocks, you're not alone. According to insider tracker Form 4 Oracle, executives at these three firms cashed in shares this week: The week's selling Sources: Fool.com, Yahoo! Finance, Form 4...
Today was another sharply negative day and it was ugly all session. It started off with a big gap down. They went sharply lower in the morning, bounced late in the morning and then stair-stepped lower in a shallower angle, but...
| Request a Trial to NEW EDGAR Online Pro Form 10-Q for AVALON PHARMACEUTICALS INC Item 2. Since our inception, our operations have consisted primarily of developing AvalonRx_, utilizing our technology to seek to discover and...
The stock market had very positive results at the end of the day today, but did have a difficult afternoon. The day started out with a gap up, a very strong run in the morning, and then they backed and filled mid-morning,...
Wednesday September 24, 4:55 pm ET By the tickerspy.com Staff Stocks meandered most of the trading day, eventually finishing mixed. Warren Buffett stole the headlines when he revealed last night that Berkshire Hathaway...
BOSTON (MarketWatch) -- Shares of Vertex Pharmaceuticals rocketed in afternoon trading Wednesday, fueled by the release of positive data for its hepatitis C drug candidate telaprevir. The Cambridge, Mass. biotech group...